The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles, Debashis Sahoo, Piero Dalerba, Siddhartha S. Mitra, Jian Wang, Humberto Contreras-Trujillo, R.K. Martin, Justin D. Cohen, Patricia Lovelace, Ferenc A. Scheeren, Mark P. Chao, Kipp Weiskopf, Chad Tang, Anne Kathrin Volkmer, Tejaswitha Jairaj Naik, Theresa A. Storm, Adriane Mosley, Badreddin Edris, Seraina Schmid, Chris K. Sun, Mei‐Sze Chua, Oihana Murillo, Pradeep S. Rajendran, Adriel C. Cha, Robert Chin, Dongkyoon Kim, Maddalena Adorno, Tal Raveh, Diane Tseng, Siddhartha Jaiswal, Per Øyvind Enger, Gary K. Steinberg, Gordon Li, Samuel So, Ravindra Majeti, Griffith R. Harsh, Matt van de Rijn, Nelson N.H. Teng, John B. Sunwoo, Ash A. Alizadeh, Michael F. Clarke, Irving L. Weissman
Proceedings of the National Academy of Sciences, 2012
Abstract
This research paper explore the methodology and findings associated with Proceedings of the National Academy of Sciences. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).